Many African-Americans have a gene that prolongs life after heart failure

About 40 percent of African-Americans have a genetic variant that can protect them after heart failure and prolong their lives, according to research conducted at the School of Medicine and collaborating institutions. The genetic variant has an effect that resembles that of beta blockers, drugs widely prescribed for heart failure. The new study offers a reason why beta blockers don’t appear to benefit some African-Americans.

Readily available treatment could help prevent heart disease in kidney patients

The estimated 19 million Americans living with chronic kidney disease (CKD) face a high risk of death from cardiovascular disease, usually related to high levels of blood phosphate. Now researchers at the School of Medicine have demonstrated that high blood phosphate directly stimulates calcification of blood vessels and that phosphate-binding drugs can decrease vascular calcification.

Washington University in St. Louis and AstraZeneca announce Alzheimer’s research collaboration

The School of Medicine and the pharmaceutical company AstraZeneca (NYSE:AZN) have announced a research collaboration that aims to develop new and improved ways to diagnose and treat Alzheimer’s disease. The major focus of the alliance will be biomarkers, characteristic changes in the brain and spinal fluid that physicians can use to diagnose Alzheimer’s disease and track its response to treatment.

‘Put on a happy face’

Courtesy Photo”Bye Bye Birdie,” the spring musical production by School of Medicine students, will be held April 24, 25 and 26 at the Whelpley Auditorium on the St Louis College of Pharmacy campus.
View More Stories